Skip to main content
OpenTrials
Completed

NCT Number: NCT01597830

The Effects of Specialized Footwear in Osteoarthritis

This study evaluates the effects of specialized footwear on pain and knee loading in knee osteoarthritis. The hypothesis is that this footwear will lead to decreased knee loading and knee pain.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rush University Medical Center

Chicago, Illinois, 60612, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able and willing to give informed consent and to comply with the study protocol and follow-up instructions.
  • Symptomatic OA of the knee, as defined by the American College of Rheumatology's Clinical Criteria for Classification and Reporting of OA of the Knee. If symptoms are bilateral, then the knee identified by the subject as more symptomatic will serve as the index knee.
  • Ambulatory knee pain, defined as the presence of greater than 30 mm of pain while walking on a flat surface (corresponding to question 1 of the visual analog format of the WOMAC.
  • Radiographic OA of the study knee of grade 2 or 3, as defined by the modified Kellgren and Lawrence (K-L) grading scale.
  • Medial compartment OA, defined as either qualitative joint space narrowing of ≥ 1or the presence of medial bone cyst, sclerosis, or osteophyte.

Exclusion criteria

  • Inability or unwillingness to wear study shoes for at least 6 hours/day for 6 days/week
  • Knee flexion contracture of > 15 degrees or inability to ambulate without assistance.
  • Presence of clinically significant OA of the hip or ankle or pain greater than 20 mm at these sites (WOMAC).
  • > 3 degrees valgus or >12 degrees varus deformity of either knee, defined by the mechanical axis (hip-knee angle).
  • Predominant lateral compartment OA, defined as narrowing of the lateral joint space in excess of the narrowing of the medial joint space in either the index or the contralateral knee.
  • Concurrent systemic inflammatory arthropathy,
  • Prior knee or hip arthroplasty, or surgical arthroscopy of either knee within previous 3 months or history of fracture of either lower extremity within 6 months of study entry.
  • Intrinsic foot disease including hallux rigidus, hallux abducto-valgus, metatarsalgia, plantar fasciitis, peripheral neuropathy, or any foot condition that may be exacerbated by particular footwear.
  • Intra-articular injection in the index knee: steroids within 6 weeks, hyaluronan derivatives within 4 months.
  • Pregnant subjects will be excluded because of the X-rays required.
  • Any medical condition that, in the opinion of the PI, would render the subject unable to complete the study.

Treatment and study plan

Mobility shoe

Other

flat, specialized shoe

control shoe

Other

control shoe

Primary outcomes

  1. Dynamic knee loading

    Time frame: 6 months to 2 years

Sponsors and collaborators

Lead sponsor

Rush University Medical Center

Other

Collaborators

  • Arthritis Foundation

Registry information

Important dates

Study start
2007
Primary completion
2013
First posted
May 14, 2012
Registry last updated
Apr 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.